Earnings Per Share, Basic of Panbela Therapeutics, Inc. from 31 Dec 2011 to 30 Sep 2024

Taxonomy & unit
us-gaap: USD/shares
Description
The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.
Summary
Panbela Therapeutics, Inc. quarterly and annual Earnings Per Share, Basic in USD/shares history and change rate from 31 Dec 2011 to 30 Sep 2024.
  • Panbela Therapeutics, Inc. Earnings Per Share, Basic for the quarter ending 30 Sep 2024 was -1.48, a 97% increase year-over-year.
  • Panbela Therapeutics, Inc. Earnings Per Share, Basic for the twelve months ending 30 Sep 2024 was 284.
  • Panbela Therapeutics, Inc. annual Earnings Per Share, Basic for 2023 was -317.
  • Panbela Therapeutics, Inc. annual Earnings Per Share, Basic for 2022 was -41,341.
  • Panbela Therapeutics, Inc. annual Earnings Per Share, Basic for 2021 was -34.64.
Source SEC data
View on sec.gov
Earnings Per Share, Basic, Trailing 12 Months (USD/shares)
Earnings Per Share, Basic, Quarterly (USD/shares)
Earnings Per Share, Basic, YoY Quarterly Change (%)
Earnings Per Share, Basic, Annual (USD/shares)
Earnings Per Share, Basic, YoY Annual Change (%)

Panbela Therapeutics, Inc. Quarterly Earnings Per Share, Basic (USD/shares)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q3 2024 284 -1.48 +52.26 +97% 01 Jul 2024 30 Sep 2024 10-Q 14 Nov 2024 2024 Q3
Q2 2024 232 -1.47 +158 +99% 01 Apr 2024 30 Jun 2024 10-Q 13 Aug 2024 2024 Q2
Q1 2024 74 -2.28 +390 +99% 01 Jan 2024 31 Mar 2024 10-Q 15 May 2024 2024 Q1
Q4 2023 -317 289 01 Oct 2023 31 Dec 2023 10-K 26 Mar 2024 2023 FY
Q3 2023 -53.74 +204 +79% 01 Jul 2023 30 Sep 2023 10-Q 14 Nov 2024 2024 Q3
Q2 2023 -159 +1,685 01 Apr 2023 30 Jun 2023 10-Q 13 Aug 2024 2024 Q2
Q1 2023 -393 -382 -3500% 01 Jan 2023 31 Mar 2023 10-Q 15 May 2024 2024 Q1
Q3 2022 -2,146 -257 -257 -160750% 01 Jul 2022 30 Sep 2022 10-Q 09 Nov 2023 2023 Q3
Q2 2022 -1,889 -1,844* -1,843 01 Apr 2022 30 Jun 2022 10-Q 10 Aug 2023 2023 Q2
Q1 2022 -45 -10.91 -10.68 -4643% 01 Jan 2022 31 Mar 2022 10-Q 04 May 2023 2023 Q1
Q4 2021 -35 -34.03 01 Oct 2021 31 Dec 2021 10-K 16 Mar 2023 2022 FY
Q3 2021 -0.16 01 Jul 2021 30 Sep 2021 10-Q 10 Nov 2022 2022 Q3
Q2 2021 -0.22 01 Apr 2021 30 Jun 2021 10-Q 15 Aug 2022 2022 Q2
Q1 2021 -0.23 01 Jan 2021 31 Mar 2021 10-Q 12 May 2022 2022 Q1
Q4 2013 0 -0.03 -0.11 -138% 01 Oct 2013 31 Dec 2013 10-K 28 Mar 2014 2013 FY
Q3 2013 0 -0.04 -0.09 -180% 01 Jul 2013 30 Sep 2013 10-Q 14 Nov 2013 2013 Q3
Q2 2013 0 -0.03 -0.09 -150% 01 Apr 2013 30 Jun 2013 10-Q 14 Aug 2013 2013 Q2
Q1 2013 0 -0.05 -0.03 -150% 01 Jan 2013 31 Mar 2013 10-Q 15 May 2013 2013 Q1
Q4 2012 0 0.08 01 Oct 2012 31 Dec 2012 10-K 28 Mar 2014 2013 FY
Q3 2012 0.05 01 Jul 2012 30 Sep 2012 10-Q 14 Nov 2013 2013 Q3
Q2 2012 0.06 01 Apr 2012 30 Jun 2012 10-Q 14 Aug 2013 2013 Q2
Q1 2012 -0.02 01 Jan 2012 31 Mar 2012 10-Q 15 May 2013 2013 Q1

Panbela Therapeutics, Inc. Annual Earnings Per Share, Basic (USD/shares)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2023 -317 +41,025 01 Jan 2023 31 Dec 2023 10-K 26 Mar 2024 2023 FY
2022 -41,341* -41,307 01 Jan 2022 31 Dec 2022 10-K 26 Mar 2024 2023 FY
2021 -34.64 01 Jan 2021 31 Dec 2021 10-K 16 Mar 2023 2022 FY
2013 -0.15 -0.32 -188% 01 Jan 2013 31 Dec 2013 10-K 28 Mar 2014 2013 FY
2012 0.17 +0.27 01 Jan 2012 31 Dec 2012 10-K 28 Mar 2014 2013 FY
2011 -0.1 01 Jan 2011 31 Dec 2011 10-K 26 Mar 2013 2012 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.